Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan

Oral Oncology

Volumn 38, Issue 1, 2002, Pages 56-63

  Chiang, C P ^a   Wu, H Y ^a   Liu, B Y ^a   Wang, J T ^a   Kuo, M Y P ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Areca quid chewing; B lymphocytes; Macrophages; Oral submucous fibrosis; T lymphocytes

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MACROPHAGE; MOUTH DISEASE; MOUTH MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE GENETICS; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CONNECTIVE TISSUE CELLS; EPITHELIAL CELLS; FEMALE; HUMANS; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; ORAL SUBMUCOUS FIBROSIS; T-LYMPHOCYTES;

EID: 0036145094     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00026-4     Document Type: Article

References (29)

1. Role of areca nut in the causation of oral submucous fibrosis: A case-control study in Pakistan
2. Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing
3. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): A case-control study
4. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors
5. Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan
6. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia
7. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids
8. Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase
9. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis
10. Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures
11. Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan
12. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma
13. Collagenase activity in oral submucous fibrosis
14. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis
15. Subepithelial changes in oral submucous fibrosis
16. An immunohistochemical study of oral submucous fibrosis
17. Immunolocalization of cytokines and growth factors in oral submucous fibrosis
18. Oral submucous fibrosis patients have altered levels of cytokine production
19. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
20. Interleukin-1, a potential regulator of fibroblast proliferation
21. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors
22. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure
23. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis
24. TNF-alpha inactivation of collagen receptors - Implications for fibroblast function and fibrosis
25. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis
26. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity
27. The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model
28. Intralesional interferon gamma treatment for keloids and hypertrophic scars
29. Interferon gamma reverses oral submucous fibrosis (OSF)